North America Leads the Pharmaceutical Grade Probiotics Market
North America has established itself as the dominant region in the global Pharmaceutical Grade Probiotics Market, driven by high consumer awareness, advanced healthcare infrastructure, and significant investment in microbiome research. The region accounted for a substantial share in 2024, valued at approximately USD 729 million, and is projected to reach USD 1.4 billion by 2035. The region's...
0 Σχόλια 0 Μοιράστηκε 0 Προεπισκόπηση